Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CDKN2A |
| Upstream (Parents) |
|---|
| (<<) CASP3 → CDKN2A |
| (<<) FOSL1 → CDKN2A |
| (<<) GNG12 → CDKN2A |
| (<<) GRB7 → CDKN2A |
| (<<) GSTZ1 → CDKN2A |
| (<<) GYPC → CDKN2A |
| (<<) HEY1 → CDKN2A |
| (<<) IL1A → CDKN2A |
| (<<) IL1R2 → CDKN2A |
| (<<) ISG20 → CDKN2A |
| (<<) LIF → CDKN2A |
| (<<) MLPH → CDKN2A |
| (<<) RHOC → CDKN2A |
| (<<) STX1A → CDKN2A |
| (<<) TTC9 → CDKN2A |
| (<<) VANGL1 → CDKN2A |
| (<<) VPS37B → CDKN2A |
| (<<) YRDC → CDKN2A |
| Downstream (Children) |
|---|
| CDKN2A → ARSJ (>>) |
| CDKN2A → ATP2B1 (>>) |
| CDKN2A → DNAJA4 (>>) |
| CDKN2A → DUSP6 (>>) |
| CDKN2A → EPHA4 (>>) |
| CDKN2A → GNA12 (>>) |
| CDKN2A → KYNU (>>) |
| CDKN2A → PLA2G4A (>>) |
| CDKN2A → STK17B (>>) |
